Publicaciones en las que colabora con JOSE RAMON VIDAL CASTIÑEIRA (23)

2022

  1. Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study

    eLife, Vol. 11

2021

  1. The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19

    Cytokine, Vol. 137

2020

  1. Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection

    Journal of Molecular Medicine, Vol. 98, Núm. 9, pp. 1245-1254

2019

  1. Effect of Type of Dialysis on CMV-Specific CD8+ T Cells in Kidney Transplant Candidates

    Frontiers in immunology, Vol. 10, pp. 1680

  2. Signal Integration and Transcriptional Regulation of the Inflammatory Response Mediated by the GM-/M-CSF Signaling Axis in Human Monocytes

    Cell Reports, Vol. 29, Núm. 4, pp. 860-872.e5

2018

  1. Correction to "Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition" [Oncotarget. 2017; 8:31959-31976]. Doi: https://doi.org/10.18632/oncotarget.16657

    Oncotarget

2017

  1. Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C

    PLoS ONE, Vol. 12, Núm. 7

2016

  1. A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis

    PLoS ONE, Vol. 11, Núm. 7

  2. HLA-B∗ 40: 01 is associated with ankylosing spondylitis in HLA-B27-positive populations

    Journal of Rheumatology

  3. Significant association of the KIR2DL3/HLA-C1 genotype with susceptibility to Crohn's disease

    Human Immunology, Vol. 77, Núm. 1, pp. 104-109

2015

  1. Activating killer immunoglobulin-like receptors genes are associated with increased susceptibility to ankylosing spondylitis

    Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 201-206

2014

  1. Autoantibodies against MHC class I polypeptide-related sequence A are associated with increased risk of concomitant autoimmune diseases in celiac patients

    BMC Medicine, Vol. 12, Núm. 1

  2. Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome

    PLoS ONE, Vol. 9, Núm. 6

2013

  1. Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapy

    Genes and Immunity, Vol. 14, Núm. 5, pp. 317-324

2012

  1. A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping

    Journal of Hepatology, Vol. 56, Núm. 6, pp. 1230-1238

  2. Immunosuppression in the ERA of biological agents

    Advances in Experimental Medicine and Biology, Vol. 741, pp. 60-72

2011

  1. Erratum to: Endoplasmic Reticulum Stress Signals in Defined Human Embryonic Stem Cell Lines and Culture Conditions(Stem Cell Rev and Rep, DOI 10.1007/s12015-010-9135-4)

    Stem Cell Reviews and Reports

  2. IL-15 preferentially enhances functional properties and antigen-specific responses of CD4+CD28 null compared to CD4+CD28+ T cells

    Aging Cell, Vol. 10, Núm. 5, pp. 844-852

2010

  1. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing Spondylitis

    Arthritis and Rheumatism, Vol. 62, Núm. 4, pp. 1000-1006

  2. Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection

    Journal of Virology, Vol. 84, Núm. 1, pp. 475-481